Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department

NCT03576820 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Migraine

Interventions

DRUG: Lidocaine
DRUG: Placebo

Sponsor

New York City Health and Hospitals Corporation